Agents and methods for early diagnosis and monitoring of Alzheimer's disease and other neurological disorders

Details for Australian Patent Application No. 2005321021 (hide)

Owner Ferguson, I. Tani, H.

Inventors Ferguson, Ian A.; Tani, Hiroaka

Agent Davies Collison Cave

Pub. Number AU-B-2005321021

PCT Pub. Number WO2006/070290

Priority 2004/903380 23.06.04 AU

Filing date 23 June 2005

Wipo publication date 6 July 2006

Acceptance publication date 24 November 2011

International Classifications

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61K 101/02 (2006.01)

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/070290 Priority application(s): WO2006/070290

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

27 January 2011 Corrigenda

  Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2005 Delete all reference to Application No. 2005321021.

24 November 2011 Application Accepted

  Published as AU-B-2005321021

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005321022-Surface-modified activated carbon in smoking articles

2005321017-Monoclonal antibodies against NKG2A